Sign in

CIK 0001622229 · Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465308248
Phone
617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
  1. PRE 14A Proxy Proxy Statement (Preliminary)
  2. EFFECT Other Notice of Effectiveness
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. 4 Derivatives Options or other derivatives
  6. SC 13D/A Stake Beneficial Ownership Report
  7. 4 Other disposition Director disposed of 286,851 shares (other)
  8. S-3 Offering Registration Statement
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 8-K Event Unregistered share sale · Bylaws or fiscal year change
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations
  14. SC 13D/A Stake Beneficial Ownership Report
  15. 4 Grant or award 10% owner acquired 1,166,666 shares (grant or award)
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 9 of 31 · 616 filings